TrialScientific reports2022

Intranasal insulin modulates cerebrospinal fluid markers of neuroinflammation in mild cognitive impairment and Alzheimer's disease: a randomized trial.

Derek Kellar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.